XML 22 R9.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
CONSOLIDATED STATEMENTS OF CASH FLOWS    
Net income $ 35,585 $ 26,438
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Gain on sale of investment securities (435) (1,345)
Net amortization of investment premiums and discounts and change in fair value of equity securities 1,369 425
Depreciation and amortization, net (5,922) (2,890)
Provision for loan losses 1,070 8,302
Amortization of issuance costs on subordinated debt 118 112
Share-based compensation 1,607 763
Net change in fair value of derivative instruments 4,338 (4,975)
Net change in fair value of loans held for sale 3,311 (3,847)
Net change in fair value of loans held for investment 189 (323)
Gain on sale of OREO   (6)
Amortization and net impairment of servicing rights 1,109 816
SBA loan income (6,898) (2,733)
Proceeds from sale of loans 2,483,373 2,235,986
Loans originated for sale (2,270,693) (2,356,821)
Mortgage banking income (75,932) (77,116)
Decrease (increase) in accrued interest receivable 473 (2,334)
Increase (decrease) in other assets (3,693) 8,995
Earnings from investment in life insurance (365) (279)
(Increase) decrease income in deferred income tax (768) 1,254
(Decrease) in accrued interest payable (1,122) 66
(Decreased) increase in other liabilities (1,591) 11,047
Net cash provided by (used in) operating activities 165,123 (158,465)
Activity in available-for-sale securities:    
Maturities, repayments and calls 10,447 8,247
Sales 23,585 45,927
Purchases (74,341) (114,494)
Activity in held-to-maturity securities:    
Maturities, repayments and calls   2,140
Proceeds from sale of OREO   126
Decrease in restricted stock 2,743 211
Net increase in loans (87,575) (312,112)
Purchases of premises and equipment (5,374) (747)
Purchase of bank owned life insurance (10,000)  
Net cash used in investing activities (140,515) (370,702)
Cash flows from financing activities:    
Net increase in deposits 205,079 390,167
Decrease in short-term borrowings (44,939) (922)
Decrease in short-term borrowings with original maturity > 90 days (20,579) (15,479)
Repayment of long-term debt (subordinated debt) (281) (172)
(Repayment) proceeds from long-term debt, net (165,546) 162,423
Repayment of acquisition note payable   (413)
Issuance costs on subordinated debt   (231)
Net purchase of treasury stock (3,032) (5,703)
Dividends paid (9,679) (1,525)
Purchase of common shares for ESOP   (2,000)
Share based awards and exercises 1,105 395
Net cash (used in) provided by financing activities (37,872) 526,540
Net change in cash and cash equivalents (13,264) (2,627)
Cash and cash equivalents at beginning of period 36,744 39,371
Cash and cash equivalents at end of period 23,480 36,744
Supplemental disclosure of cash flow information:    
Interest 9,534 13,594
Income taxes 14,069 5,295
Supplemental disclosure of cash flow information:    
Transfers from loans held for sale to loans held for investment $ 8,410 3,313
Net loans purchased, not settled   $ 325